Cesarean scar pregnancy, incidence, and recurrence: Five-year experience at a single tertiary care referral center

Olga Grechukhina, Uma Deshmukh, Linda Fan, Katherine Kohari, Sonya Abdel-Razeq, Mert Ozan Bahtiyar, Anna K. Sfakianaki

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

OBJECTIVE: To describe the treatment and subsequent pregnancy outcomes in patients with cesarean scar pregnancies at a single institution over 5 years. METHODS: This is a case series of all cesarean scar pregnancies diagnosed from May 2013 to March 2018 at Yale-New Haven Hospital. Data were collected on each patient using electronic medical record review and included patient demographics; medical, surgical, and obstetric history; pregnancy characteristics; treatment modalities used; response to therapy; complications; and subsequent pregnancy outcomes. RESULTS: Thirty cases of cesarean scar pregnancies were diagnosed in 26 patients, including one recurrence in one patient and three recurrences in another. Forty-six percent of cesarean scar pregnancies were in Hispanic women. The median number of prior cesarean deliveries was two. Mean gestational age at the time of diagnosis was 46 days (SD±10). Fetal cardiac activity was detected in 18 cases. Three patients initially were erroneously diagnosed with a viable intrauterine pregnancy and failed medical termination. Others opted for termination through systemic methotrexate alone (n54), systemic and local methotrexate (n512), systemic and local methotrexate with potassium chloride injected into the gestational sac (n53), potassium chloride injection with laparotomy and wedge resection (n51), methotrexate with bilateral uterine artery embolization (n52), or intrauterine balloon (n54). Five patients who underwent expectant management or methotrexate therapy had retained products of conception and required hysteroscopy and curettage. One patient opted for hysterectomy after failed curettage. After complete resolution of cesarean scar pregnancies, there were 10 subsequent spontaneous conceptions in eight patients, including four recurrent cesarean scar pregnancies, four term pregnancies, and one spontaneous abortion. One viable normally located pregnancy is ongoing. CONCLUSION: There is a wide array of treatment modalities available for cesarean scar pregnancies. Women with a cesarean scar pregnancy are at risk for its recurrence in the future, although normal pregnancy after a cesarean scar pregnancy is also possible. Safe outcomes depend on timely diagnosis and multidisciplinary care by skilled clinicians.

Original languageEnglish (US)
Pages (from-to)1285-1295
Number of pages11
JournalObstetrics and gynecology
Volume132
Issue number5
DOIs
StatePublished - 2018
Externally publishedYes

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Cesarean scar pregnancy, incidence, and recurrence: Five-year experience at a single tertiary care referral center'. Together they form a unique fingerprint.

Cite this